Robert Hofmeister - Mar 30, 2023 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Mar 30, 2023
Transactions value $
$0
Form type
4
Date filed
4/19/2023, 05:00 PM
Previous filing
Dec 10, 2021
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +150K $0.00 150K Mar 30, 2023 Common Stock 150K $0.66 Direct F1
transaction TCRT Employee Stock Option (right to buy) Award $0 +16.7K $0.00 16.7K Mar 30, 2023 Common Stock 16.7K $0.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from March 30, 2023, with the first vesting occuring on April 30, 2023, subject to the Reporting Person's continued service through each such date.
F2 In equal installments on April 30, 2023 and May 30, 2023, subject to the Reporting Person's continued service through each such date.